David A. Simon
@davidasimon.bsky.social
Associate Professor, Northeastern University School of Law
www.davidasimon.us
Co-Director, Amy J. Reed Collaborative for Medical Device Safety
https://www.safemedicaldevices.org/
Researcher, the CLASSICA Project
https://classicaproject.eu/team/
www.davidasimon.us
Co-Director, Amy J. Reed Collaborative for Medical Device Safety
https://www.safemedicaldevices.org/
Researcher, the CLASSICA Project
https://classicaproject.eu/team/
Reposted by David A. Simon
In an interview with U.S. News & World Report, Professor David Simon @davidasimon.bsky.social weighs in on what happens when AI makes a mistake — and who’s accountable. @clicatnusl.bsky.social
health.usnews.com/health-care/...
health.usnews.com/health-care/...
health.usnews.com
November 25, 2025 at 3:43 PM
In an interview with U.S. News & World Report, Professor David Simon @davidasimon.bsky.social weighs in on what happens when AI makes a mistake — and who’s accountable. @clicatnusl.bsky.social
health.usnews.com/health-care/...
health.usnews.com/health-care/...
I spoke with @mathurashton.bsky.social of US News to discuss how AI is changing healthcare
health.usnews.com/health-care/...
health.usnews.com/health-care/...
health.usnews.com
November 25, 2025 at 3:21 PM
I spoke with @mathurashton.bsky.social of US News to discuss how AI is changing healthcare
health.usnews.com/health-care/...
health.usnews.com/health-care/...
anyone tried this?
November 24, 2025 at 9:37 PM
anyone tried this?
After having my head drilled open, I wasn't sure how quickly I'd be back in the classroom. @nusl.bsky.social colleagues supported me the whole way. I returned to teaching in September and had a great semester. Our students couldn't have been better or kinder. Thanks to all who provided support.
November 24, 2025 at 7:30 PM
After having my head drilled open, I wasn't sure how quickly I'd be back in the classroom. @nusl.bsky.social colleagues supported me the whole way. I returned to teaching in September and had a great semester. Our students couldn't have been better or kinder. Thanks to all who provided support.
Reposted by David A. Simon
Especially for the 1Ls out there, preparing for their 1st set of law school exams, I wrote this post back in 2007 about how to get a good grade on a law school issue spotter. The post, "Bad Answers, Good Answers, and Terrific Answers," is available here:
volokh.com/posts/116838...
volokh.com/posts/116838...
November 22, 2025 at 6:12 AM
Especially for the 1Ls out there, preparing for their 1st set of law school exams, I wrote this post back in 2007 about how to get a good grade on a law school issue spotter. The post, "Bad Answers, Good Answers, and Terrific Answers," is available here:
volokh.com/posts/116838...
volokh.com/posts/116838...
Reposted by David A. Simon
It's up! www.yalejreg.com/nc/trump-reg...
Trump Regulatory Policy: 2025 Compendium - Yale Journal on Regulation
As part of my prep for this year’s ABA Administrative Law Conference, I put together a list of the regulatory policy documents that have been issued since the start of President Trump’s second term. L...
www.yalejreg.com
November 21, 2025 at 3:33 PM
It's up! www.yalejreg.com/nc/trump-reg...
November 17, 2025 at 1:35 PM
Reposted by David A. Simon
Will repost on Monday but here’s some Saturday night reading—a new paper
papers.ssrn.com/sol3/papers....
papers.ssrn.com/sol3/papers....
November 16, 2025 at 1:19 AM
Will repost on Monday but here’s some Saturday night reading—a new paper
papers.ssrn.com/sol3/papers....
papers.ssrn.com/sol3/papers....
Will repost on Monday but here’s some Saturday night reading—a new paper
papers.ssrn.com/sol3/papers....
papers.ssrn.com/sol3/papers....
November 16, 2025 at 1:19 AM
Will repost on Monday but here’s some Saturday night reading—a new paper
papers.ssrn.com/sol3/papers....
papers.ssrn.com/sol3/papers....
maybe, but depends on which drugs - for example, there is a cancer drug--that may qualify for mandatory off-label use reimbursement depending on compendia ratings.
November 13, 2025 at 7:51 PM
maybe, but depends on which drugs - for example, there is a cancer drug--that may qualify for mandatory off-label use reimbursement depending on compendia ratings.
Medical treatments can work, but they don't always --or even work the same for everyone. And sometimes taking a medication is only one aspect of the treatment. Med often runs out of solutions in the standard playbook. People then head elsewhere. They may not get better, but they will get something
November 13, 2025 at 2:35 PM
Medical treatments can work, but they don't always --or even work the same for everyone. And sometimes taking a medication is only one aspect of the treatment. Med often runs out of solutions in the standard playbook. People then head elsewhere. They may not get better, but they will get something
November 13, 2025 at 1:38 PM
Reposted by David A. Simon
Below the line of the 1st page of Professor Dan Burk's last article, just published posthumously by the UC Irvine Law Review.
November 13, 2025 at 12:18 AM
Below the line of the 1st page of Professor Dan Burk's last article, just published posthumously by the UC Irvine Law Review.
It’s a shame because I met so many friends and colleagues on Twitter, and learned about interesting new ideas.
*was normal in the old days of twitter
November 12, 2025 at 3:54 PM
It’s a shame because I met so many friends and colleagues on Twitter, and learned about interesting new ideas.
social media has become less relevant for me. there is 0 engagement on twitter. very little here. not sure how much longer i'll be here. i still find out about neat papers, but far less frequently than normal
November 11, 2025 at 5:36 PM
social media has become less relevant for me. there is 0 engagement on twitter. very little here. not sure how much longer i'll be here. i still find out about neat papers, but far less frequently than normal
Reposted by David A. Simon
Thank you to the editors of the Harvard Law Review and to many commentators.
harvardlawreview.org/print/vol-13...
harvardlawreview.org/print/vol-13...
To a Conservative Warren Court - Harvard Law Review
The Warren Court’s legacy is ubiquitous. With the eponymous Chief Justice Warren at the helm, the Supreme Court featured a strong majority of left-of-center jurists, and those “liberal lions” ruled (o...
harvardlawreview.org
November 11, 2025 at 12:06 PM
Thank you to the editors of the Harvard Law Review and to many commentators.
harvardlawreview.org/print/vol-13...
harvardlawreview.org/print/vol-13...
saw a table from microsoft that AI will be very likely to displace historians and I wonder if the people who made the chart really contemplated what historians do.
November 10, 2025 at 7:21 PM
saw a table from microsoft that AI will be very likely to displace historians and I wonder if the people who made the chart really contemplated what historians do.
Is this ever appropriate or do I have to make a section IV.
November 7, 2025 at 8:40 PM
Is this ever appropriate or do I have to make a section IV.
always the problem. draft is nearly finished at 17000 words. then I edit and now its 21,000 words. want to shave but can't figure out what's best given what I need to cover. I think i will save it for another, more general paper--perhaps an online essay.
November 7, 2025 at 2:55 PM
always the problem. draft is nearly finished at 17000 words. then I edit and now its 21,000 words. want to shave but can't figure out what's best given what I need to cover. I think i will save it for another, more general paper--perhaps an online essay.
Many of us know what it's like to watch a family member develop early-onset Alzheimer's - sometimes more than one. It is horrible, and it should motivate us to fund more research into the disease and treatments.
www.inquirer.com/health/a/rot...
www.inquirer.com/health/a/rot...
Former Rothman CEO Mike West didn’t want to burden his family with his Alzheimer’s. He quietly planned his suicide.
Only 200,000, or 3%, are diagnosed with Alzheimer's before age 65. Such an early onset means the disease is more likely to progress rapidly and shorten their lives.
www.inquirer.com
November 7, 2025 at 1:06 PM
Many of us know what it's like to watch a family member develop early-onset Alzheimer's - sometimes more than one. It is horrible, and it should motivate us to fund more research into the disease and treatments.
www.inquirer.com/health/a/rot...
www.inquirer.com/health/a/rot...
Too early to tell but if things continue the Bulls will be the biggest surprise in sports. And it would be a welcome surprise
November 5, 2025 at 4:56 PM
Too early to tell but if things continue the Bulls will be the biggest surprise in sports. And it would be a welcome surprise
The reality is it costs a lot of money to fund research and the only viable entity that can do it in most cases is the government
www.statnews.com/2025/11/04/a...
www.statnews.com/2025/11/04/a...
Arena BioWorks, an ambitious biomedical institute backed by billionaires, abruptly shuts down
Exclusive: Arena Bioworks, the buzzy research institute that launched with $500 million to support a decade of scientific R&D, is abruptly shutting down, STAT has learned.
www.statnews.com
November 5, 2025 at 12:15 PM
The reality is it costs a lot of money to fund research and the only viable entity that can do it in most cases is the government
www.statnews.com/2025/11/04/a...
www.statnews.com/2025/11/04/a...